Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)

NCT05877508 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Long COVID
Post-Acute Sequela of COVID-19
Post-Acute COVID-19

Interventions

DRUG: AER002
OTHER: Placebo

Sponsor

Michael Peluso, MD

Collaborators

[object Object]
[object Object]
[object Object]